Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer

Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer

US Patent 12473547 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating heart failure2025
Treatment of immune disorders2025
Prevention of progressive heart failure2024
Method for treating heart failure2023
Prevention of progressive heart failure2022
Treatment of immune disorders2022
Stem cell composition2022
Methods for increasing osteoblastic function2021
Method of treating graft versus host disease2020
Methods of treating or preventing respiratory conditions2020
Methods for repairing tissue damage using protease-resistant mutants of stromal 2020
Treatment of immune disorders2020